![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Hubei Haosun Pharmaceutical Co., Ltd. Ezhou Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Flumazenil, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2008-121 - Rev 02
This Chemical Type CEP, issued on September 14, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1326 associated with this CEP further emphasizes